ITK Inhibitors in Inflammation and Immune-Mediated Disorders

E-ISSN： 1873-4294|9|8|690-703

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.8, 2009-05, pp. : 690-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 4, 2007-12 ,pp. : 223-235

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the design of ITK inhibitors

By Charrier Jean-Damien Knegtel Ronald MA

Expert Opinion on Drug Discovery, Vol. 8, Iss. 4, 2013-04 ,pp. : 369-381

Informa Healthcare

Access to resources Recommend Favorite

Itk inhibitors: a patent review

By Lo Ho Yin

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 4, 2010-04 ,pp. : 459-469

Informa Healthcare

Access to resources Recommend Favorite

2nd International Conference on Immune-Mediated Diseases & 8th International Anti-Inflammation Meeting

By Braddock Martin

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 555-564

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives

Current Medicinal Chemistry, Vol. 24, Iss. 28, 2017-09 ,pp. : 3054-3067

Bentham Science Publishers

Access to resources Recommend Favorite